Madrigal PharmaceuticalsMIL:1MDGL 8 Days Inventory is 316.02 as of Mar. 2026, which is 73% below its 10-year median of 1,174.50. GuruFocus rates MIL:1MDGL with a GF Score™ of 8/100. The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Madrigal Pharmaceuticals ranks worse than 72.88% on this metric.
The historical rank and industry rank for Madrigal Pharmaceuticals's Days Inventory or its related term are showing as below:
MIL:1MDGL'
s Days Inventory Range Over the Past 10 Years
Min: 348.77 Med: 1174.5 Max: 1995
Current: 348.77
During the past 13 years, Madrigal Pharmaceuticals's highest Days Inventory was 1995.00. The lowest was 348.77. And the median was 1174.50.
MIL:1MDGL's Days Inventory is ranked worse than 72.88% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs MIL:1MDGL: 348.77
Madrigal Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (914.17) to Mar. 2026 (316.02).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Madrigal Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Madrigal Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.30.
Madrigal Pharmaceuticals (MIL:1MDGL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Madrigal Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Madrigal Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Madrigal Pharmaceuticals Days Inventory Related Terms
Madrigal Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1MDGL vs BMRN, AXSM, CYTK: Days Inventory Comparison
For the Biotechnology subindustry, Madrigal Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Madrigal Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Madrigal Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Madrigal Pharmaceuticals (MIL:1MDGL) has a Days Inventory of 316.02 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Madrigal Pharmaceuticals and its competitors. This is 73% below median its historical median of 1,174.50. Over the past decade, Madrigal Pharmaceuticals' Days Inventory has ranged from 348.77 to 1,995.00. According to the industry distribution chart, Madrigal Pharmaceuticals ranks #465 out of 638 companies in the Biotechnology industry, placing it in the top 72.9%.
Is Madrigal Pharmaceuticals' Days Inventory too high?
Madrigal Pharmaceuticals' current Days Inventory of 316.02 is 73% below median its 10-year median of 1,174.50. Over the past 10 years, this metric has ranged from a low of 348.77 to a high of 1,995.00. The Biotechnology industry median Days Inventory is 183.88. Madrigal Pharmaceuticals' value of 316.02 is 71.9% above this industry median. Based on the distribution chart, Madrigal Pharmaceuticals ranks #465 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Madrigal Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Madrigal Pharmaceuticals' Days Inventory compare to BMRN and AXSM?
According to the Biotechnology industry distribution chart, Madrigal Pharmaceuticals ranks #465 out of 638 companies for Days Inventory. This places Madrigal Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 183.88. Madrigal Pharmaceuticals' value of 316.02 is 71.9% above this benchmark. Historically, Madrigal Pharmaceuticals' own Days Inventory has ranged from 348.77 to 1,995.00 over the past decade. While the company's 10-year median is 1,174.50 vs. the industry median of 183.88, Madrigal Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Madrigal Pharmaceuticals's current Days Inventory of 316.02 is 71.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Madrigal Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Madrigal Pharmaceuticals's current Days Inventory is 316.02, which is 73% below median its own 10-year median of 1,174.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madrigal Pharmaceuticals stock overvalued right now?
Madrigal Pharmaceuticals (MIL:1MDGL) has a current Days Inventory of 316.02. The current Days Inventory is 316.02, which is 73% below median its 10-year median of 1,174.50 and 71.9% above the Biotechnology industry median of 183.88. Madrigal Pharmaceuticals' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Madrigal Pharmaceuticals (MIL:1MDGL), the current Days Inventory is 316.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
8GF Score
Get the complete analysis for MIL:1MDGL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1MDGL has been successfully added to your 
